Cancer-associated fibroblasts impair the cytotoxic function of NK cells in gastric cancer by inducing ferroptosis via iron regulation

• DOI: 10.1016/j.redox.2023.102923
• Publication Date: 2023-10-06T06:20:39Z
• Authors: Lizhong Yao; Junyi Hou; Xiongyan Wu; Yifan Lu; Zhijian Jin; Zhenjia Yu; Beiqin Yu; Jianfang Li; Zhongyin Yang; Chen Li; Min Yan; Zhenggang Zhu; Bingya Liu; Chao Yan; Liping Su
• Keywords: Medicine (General); Follistatin-Related Proteins; QH301-705.5; Iron; Iron regulation; Antineoplastic Agents; NK cells; 3. Good health; Ferritinophagy; Killer Cells, Natural; R5-920; Cancer-Associated Fibroblasts; Stomach Neoplasms; Tumor Microenvironment; Humans; Ferroptosis; Biology (General); Cancer-associated fibroblasts; Research Paper

As the predominant immunosuppressive component within the tumor microenvironment (TME), cancer-associated fibroblasts (CAFs) inhibit Natural Killer cell (NK cell) activity to promote tumor progression and immune escape; however, the mechanisms of cross-talk between CAFs and NK cells in gastric cancer (GC) remain poorly understood. In this study, we demonstrate that NK cell levels are inversely correlated with CAFs abundance in human GC. CAFs impair the anti-tumor capacity of NK cells by inducing ferroptosis, a cell death process characterized by the accumulation of iron-dependent lipid peroxides. CAFs induce ferroptosis in NK cells by promoting iron overload; conversely, decreased intracellular iron levels protect NK cells against CAF-induced ferroptosis. Mechanistically, CAFs increase the labile iron pool within NK cells via iron export into the TME, which is mediated by the upregulated expression of iron regulatory genes ferroportin1 and hephaestin in CAFs. Moreover, CAF-derived follistatin like protein 1(FSTL1) upregulates NCOA4 expression in NK cells via the DIP2A-P38 pathway, and NCOA4-mediated ferritinophagy is required for CAF-induced NK cell ferroptosis. In a human patient-derived organoid model, functional targeting of CAFs using a combination of deferoxamine and FSTL1-neutralizing antibody significantly alleviate CAF-induced NK cell ferroptosis and boost the cytotoxicity of NK cells against GC. This study demonstrates a novel mechanism of suppression of NK cell activity by CAFs in the TME and presents a potential therapeutic approach to augment the immune response against GC mediated by NK cells.